Mechanisms of sepsis-induced organ dysfunction

Critical Care Medicine

Volumn 35, Issue 10, 2007, Pages 2408-2416

  Abraham, Edward ^a   Singer, Mervyn ^b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Multiple organ failure; Pathogenesis; Sepsis

Indexed keywords

CYTOKINE; HEAT SHOCK PROTEIN; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

BLOOD CLOTTING DISORDER; CELL INTERACTION; CELL POPULATION; CONFERENCE PAPER; GENETIC POLYMORPHISM; HUMAN; IMMUNE DYSREGULATION; LETHALITY; MEDICAL EXPERT; METABOLIC DISORDER; METABOLIC INHIBITION; MICROANGIOPATHY; MULTIPLE ORGAN FAILURE; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; SEPSIS;

HUMANS; MULTIPLE ORGAN FAILURE; SEPSIS;

EID: 34748927007     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000282072.56245.91     Document Type: Conference Paper

References (108)

1. Garcia JG, Moreno Vinasco L: Genomic insights into acute inflammatory lung injury. Am J Physiol Lung Cell Mol Physiol 2006; 291:L1113-L1117
2. Arcaroli J, Fessler MB, Abraham E: Genetic polymorphisms and sepsis. Shock 2005; 24:300-312
3. Mira JP, Cariou A, Grall F, et al: Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 1999; 282:561-568
4. Arbour NC, Lorenz E, Schutte BC, et al: TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000; 25:187-191
5. Lorenz E, Mira JP, Frees KL, et al: Relevance of mutations in the TLR4 receptor in patients with Gram-negative septic shock. Arch Intern Med 2002; 162:1028-1032
6. Arnalich F, Garcia-Palomero E, Lopez J, et al: Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis. Infect Immun 2000; 68:1942-1945
7. Yang KY, Arcaroli JJ, Abraham E: Early alterations in neutrophil activation are associated with outcome in acute lung injury. Am J Respir Crit Care Med 2003; 167:1567-1574
8. Arcaroli J, Silva E, Maloney JP, et al: Variant IRAK-1 haplotype is associated with increased nuclear factor-kappaB activation and worse outcomes in sepsis. Am J Respir Crit Care Med 2006; 173:1335-1341
9. Vincent JL, Abraham E: The last 100 years of sepsis. Am J Respir Crit Care Med 2006; 173:256-263
10. Wang H, Yang H, Tracey KJ: Extracellular role of HMGB1 in inflammation and sepsis. J Intern Med 2004; 255:320-331
11. Yang H, Wang H, Czura CJ, et al: The cytokine activity of HMGB1. J Leukoc Biol 2005; 78:1-8
12. Sadikot RT, Christman JW, Blackwell TS: Molecular targets for modulating lung inflammation and injury. Curr Drug Targets 2004; 5:581-588
13. Park JS, Gamboni-Robertson F, He Q, et al: High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol 2006; 290:C917-C924
14. Yang H, Ochani M, Li J, et al: Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Nat Acad Sci U S A 2004; 101:296-301
15. Cobb JP: Nitric oxide synthase inhibition as therapy for sepsis: A decade of promise. Surg Infect (Larchmt) 2001; 2:93-100
16. Lopez A, Lorente JA, Steingrub J, et al: Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock. Crit Care Med 2004; 32:21-30
17. Farley KS, Wang LF, Razavi HM, et al: Effects of macrophage inducible nitric oxide synthase in murine septic lung injury. Am J Physiol Lung Cell Mol Physiol 2006; 290:L1164-L1172
18. Fink MP: Reactive oxygen species as mediators of organ dysfunction caused by sepsis, acute respiratory distress syndrome, or hemorrhagic shock: Potential benefits of resuscitation with Ringer's ethyl pyruvate solution. Curr Opin Clin Nutr Metab Care 2002; 5:167-174
19. Angstwurm MW, Engelmann L, Ximmermann T, et al: Selenium in Intensive Care (SIC): Results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med 2007; 35:118-126
20. Salvemini D, Cuzzocrea S: Therapeutic potential of superoxide dismutase mimetics as therapeutic agents in critical care medicine. Crit Care Med 2003; 31(1 Suppl):S29-S38
21. Asehnoune K, Strassheim D, Mitra S, et al: Involvement of reactive oxygen species in toll-like receptor 4-dependent activation of NF-kappaB. J Immunol 2004; 172:2522-2529
22. Meng X, Harken AH: The interaction between Hsp70 and TNF-alpha expression: A novel mechanism for protection of the myocardium against post-injury depression. Shock 2002; 17:345-353
23. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348:138-150
24. Brown KA, Brain SD, Pearson JD, et al: Neutrophils in development of multiple organ failure in sepsis. Lancet 2006; 368:157-169
25. Abraham E: Alterations in cell signaling in sepsis. Clin Infect Dis 2005; 41(Suppl 7):S459-S464
26. Nussler NC, Stange B, Nussler AK, et al: Upregulation of intraepithelial lymphocyte function in the small intestinal mucosa in sepsis. Shock 2001; 16:454-458
27. Chinnaiyan AM, Huber-Lang M, Kumar-Sinha C, et al: Molecular signatures of sepsis: Multiorgan gene expression profiles of systemic inflammation. Am J Pathol 2001; 159:1199-1209
28. Cobb JP, Laramie JM, Stormo GD, et al: Sepsis gene expression profiling: Murine splenic compared with hepatic responses determined by using complementary DNA microarrays. Crit Care Med 2002; 30:2711-2721
29. Adib-Conquy M, Adrie C, Moine P, et al: NF-kappaB expression in mononuclear cells of patients with sepsis resembles that observed in lipopolysaccharide tolerance. Am J Respir Crit Care Med 2000; 162:1877-1883
30. Adib-Conquy M, Asehnoune K, Moine P, et al: Long-term-impaired expression of nuclear factor-kappa B and I kappa B alpha in peripheral blood mononuclear cells of trauma patients. J Leukoc Biol 2001; 70:30-38
31. Moore FA, Moore EE, Poggetti R, et al: Gut bacterial translocation via the portal vein: A clinical perspective with major torso trauma. J Trauma 1991; 31:629-636
32. Murphy DB, Cregg N, Tremblay L, et al: Adverse ventilatory strategy causes pulmonary-to-systemic translocation of endotoxin. Am J Respir Crit Care Med 2000; 162:27-33
33. Huston JM, Ochani M, Rosas-Ballina M, et al: Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med 2006; 203:1623-1628
34. Aird WC: The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003; 101:3765-3777
35. Boos CJ, Goon PK, Lip GY: The endothelium, inflammation, and coagulation in sepsis. Clin Pharmacol Ther 2006; 79:20-22
36. Martin TR, Nakamura M, Matute-Bello G: The role of apoptosis in acute lung injury. Crit Care Med 2003; 31(4 Suppl):S184-S188
37. Cavaillon JM, Adib-Conquy M: Monocytes/macrophages and sepsis. Crit Care Med 2005; 33(12 Suppl):S506-S509
38. Koh IH, Liberatore AM, Menchaca-Diaz JL, et al: Bacterial translocation, microcirculation injury and sepsis. Endocr Metab Immune Disord Drug Targets 2006; 6:143-150
39. Cavaillon JM, Annane D: Compartmentalization of the inflammatory response in sepsis and SIRS. J Endotoxin Res 2006; 12:151-170
40. Reddy RC, Chen GH, Newstead MW, et al: Alveolar macrophage deactivation in murine septic peritonitis: Role of interleukin 10. Infect Immun 2001; 69:1394-1401
41. Cavaillon JM, Adrie C, Fitting C, et al: Reprogramming of circulatory cells in sepsis and SIRS. J Endotoxin Res 2005; 11:311-320
42. Burnham EL, Taylor WR, Quyyumi AA, et al: Increased circulating endothelial progenitor cells are associated with survival in acute lung injury. Am J Respir Crit Care Med 2005; 172:854-860
43. Doerschuk CM: Circulating endothelial progenitor cells in pulmonary inflammation. Thorax 2005; 60:362-364
44. Zemans RL, Matthay MA: Bench-to-bedside review: The role of the alveolar epithelium in the resolution of pulmonary edema in acute lung injury. Crit Care 2004; 8:469-477
45. Matthay MA, Robriquet L, Fang X: Alveolar epithelium: Role in lung fluid balance and acute lung injury. Proc Am Thorac Soc 2005; 2:206-213
46. Levi M, Keller TT, van Gorp E, et al: Infection and inflammation and the coagulation system. Cardiovasc Res 2003; 60:26-39
47. Sakr Y, Dubois MJ, De Backer D, et al: Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 2004; 32:1825-1831
48. Singer M, De Santis V, Vitale D, et al: Multiorgan failure is an adaptive, endocrinemediated, metabolic response to overwhelming systemic inflammation. Lancet 2004; 364:545-548
49. Hotchkiss RS, Swanson PE, Freeman BD, et al: Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 1999; 27:1230-1251
50. Landry DW, Oliver JA: The pathogenesis of vasodilatory shock. N Engl J Med 2001; 345:588-595
51. Barrett LK, Singer M, Clapp LH: Vasopressin: Mechanisms of action on the vasculature in health and in septic shock. Crit Care Med 2007; 35:33-40
52. Court O, Kumar A, Parrillo JE, et al: Clinical review: Myocardial depression in sepsis and septic shock. Crit Care 2002; 6:500-508
53. Rivers E, Bryant MPH, Havstad S, et al: Early goal directed therapy in the treatment of severe sepsis and septic shock: The Early Goal-Directed Therapy Collaborative Group. N Engl J Med 2001; 345:1368-1377
54. Dahn MS, Mitchell RA, Lange MP, et al: Hepatic metabolic response to injury and sepsis. Surgery 1995; 117:520-530
55. 2 gap is associated with impaired villus microcirculation in endotoxic pigs. Intensive Care Med 2001; 27:757-766
56. Cunnion RE, Schaer GL, Parker MM, et al: The coronary circulation in human septic shock. Circulation 1986; 73:637-644
57. Langenberg C, Bellomo R, May C, et al: Renal blood flow in sepsis. Crit Care 2005; 9:R363-R374
58. Patel BM, Chittock DR, Russell JA, et al: Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002; 96:576-582
59. Spronk PE, Zandstra DF, Ince C: Bench-tobedside review: Sepsis is a disease of the microcirculation. Crit Care 2004; 8:462-468
60. VanderMeer TJ, Wang H, Fink MP: Endotoxemia causes ileal mucosal acidosis in the absence of mucosal hypoxia in a normodynamic porcine model of septic shock. Crit Care Med 1995; 23:1217-1226
61. Rosser DM, Stidwill RP, Jacobson D, et al: Oxygen tension in the bladder epithelium rises in both high and low cardiac output endotoxemic sepsis. J Appl Physiol 1995; 79:1878-1882
62. Van den Berghe G, Wouters P, Weekers F, et al: Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345:1359-1367
63. Van den Berghe G: How does blood glucose control with insulin save lives in intensive care? J Clin Invest 2004; 114:1187-1195
64. Vanhorebeek I, De Vos R, Mesotten D, et al: Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 2005; 365:53-59
65. Arnold J, Campbell IT, Samuels TA, et al: Increased whole body protein breakdown predominates over increased whole body protein synthesis in multiple organ failure. Clin Sci (Lond) 1993; 84:655-661
66. Chiolero R, Revelly JP, Tappy L: Energy metabolism in sepsis and injury. Nutrition 1997; 13(9 Suppl):45S-51S
67. Trager K, DeBacker D, Radermacher P: Metabolic alterations in sepsis and vasoactive drug-related metabolic effects. Curr Opin Crit Care 2003; 9:271-278
68. McClave SA, Snider HL: Dissecting the energy needs of the body. Curr Opin Clin Nutr Metab Care 2001; 4:143-147
69. Wischmeyer PE: The glutamine story: Where are we now? Curr Opin Crit Care 2006; 12:142-148
70. Bellingan GJ: The pathogenesis of ALI/ARDS. Thorax 2002; 57:540-546
71. Moloney ED, Griffiths MJ: Protective ventilation of patients with acute respiratory distress syndrome. Br J Anaesth 2004; 92:261-267
72. Bernard GR: Acute respiratory distress syndrome: A historical perspective. Am J Respir Crit Care Med 2005; 172:798-806
73. Bachofen M, Weibel ER: Structural alterations of lung parenchyma in the adult respiratory distress syndrome. Clin Chest Med 1982; 3:35-56
74. Martin TR, Hagimoto N, Nakamura M, et al: Apoptosis and epithelial injury in the lungs. Proc Am Thorac Soc 2005; 2:214-220
75. Vlahakis NE, Hubmayr RD: Cellular stress failure in ventilator-injured lungs. Am J Respir Crit Care Med 2005; 171:1328-1342
76. Rieux-Laucat F, Fischer A, Deist FL: Cell-death signaling and human disease. Curr Opin Immunol 2003; 15:325-331
77. Riedl SJ, Shi Y: Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 2004; 5:897-907
78. Matute-Bello G, Liles WC, Steinberg KP, et al: Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J Immunol 1999; 163:2217-2225
79. Bardales RH, Xie SS, Schaefer RF, et al: Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury. Am J Pathol 1996; 149:845-852
80. Haddad JJ: Science review: Redox and oxygen-sensitive transcription factors in the regulation of oxidant-mediated lung injury. Role for hypoxia-inducible factor-1alpha. Crit Care 2003; 7:47-54
81. Quinlan GJ, Evans TW, Gutteridge JM: Iron and the redox status of the lungs. Free Radic Biol Med 2002; 33:1306-1313
82. Maxwell PH, Ratcliffe PJ: Oxygen sensors and angiogenesis. Semin Cell Dev Biol 2002; 13:29-37
83. Dennery PA, Visner G, Weng YH, et al: Resistance to hyperoxia with heme oxygenase-1 disruption: Role of iron. Free Radic Biol Med 2003; 34:124-133
84. Anning PB, Chen Y, Lamb NJ: Iron overload upregulates haem oxygenase 1 in the lung more rapidly than in other tissues. FEBS Lett 1999; 447:111-114
85. Sharshar T, Annane D, de la Grandmaison GL, et al: The neuropathology of septic shock. Brain Pathol 2004; 14:21-33
86. Sharshar T, Hopkinson NS, Orlikowski D, et al: Science review: The brain in sepsis. Culprit and victim. Crit Care 2005; 9:37-44
87. Carrasco GA, van de Kar LD: Neuroendocrine pharmacology of stress. Eur J Pharmacol 2003; 463:235-272
88. Sharshar T, Gray F, Lorin de la Grandmaison G, et al: Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock. Lancet 2003; 362:1799-1805
89. Messaris E, Memos N, Chatzigianni E, et al: Time-dependent mitochondrial-mediated programmed neuronal cell death prolongs survival in sepsis. Crit Care Med 2004; 32:1764-1770
90. Fink MP, Delude RL: Epithelial barrier dysfunction: A unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level. Crit Care Clin 2005; 21:177-196
91. Magnotti LJ, Upperman JS, Xu DZ, et al: Gut-derived mesenteric lymph but not portal blood increases endothelial cell permeability and promotes lung injury after hemorrhagic shock. Ann Surg 1998; 228:518-527
92. Liu S, Stolz DB, Sappington PL, et al: HMGB1 is secreted by immunostimulated enterocytes and contributes to cytomix-induced hyperpermeability of Caco-2 monolayers. Am J Physiol Cell Physiol 2006; 290:C990-C999
93. +-ATPase by interferon gamma down-regulates intestinal epithelial transport and barrier function. Gastroenterology 2001; 120:1393-1403
94. Pastor CM, Billiar TR, Losser MR, et al: Liver injury during sepsis. J Crit Care 1995; 10:183-197
95. Carbonell LF, Nadal JA, Llanos MC, et al: Depletion of liver glutathione potentiates the oxidative stress and decreases nitric oxide synthesis in a rat endotoxin shock model. Crit Care Med 2000; 28:2002-2006
96. Moreno R, Vincent JL, Matos R, et al: The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care: Results of a prospective, multicentre study. Intensive Care Med 1999; 25:686-696
97. Wan L, Bellomo R, Di Giantomasso D, et al: The pathogenesis of septic acute renal failure. Curr Opin Crit Care 2003; 9:496-502
98. Di Giantomasso D, Morimatsu H, May CN, et al: Intrarenal blood flow distribution in hyperdynamic septic shock: Effect of norepinephrine. Crit Care Med 2003; 31:2509-2513
99. Cohen RI, Hassell AM, Marzouk K, et al: Renal effects of nitric oxide in endotoxemia. Am J Respir Crit Care Med 2001; 164:1890-1895
100. Carraway MS, Welty-Wolf KE, Miller DL, et al: Blockade of tissue factor: Treatment for organ injury in established sepsis. Am J Respir Crit Care Med 2003; 167:1200-1209
101. Rabuel C, Mebazaa A: Septic shock: A heart story since the 1960s. Intensive Care Med 2006; 32:799-807
102. Parker MM, Shelhamer JH, Bacharach SL, et al: Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984; 100:483-490
103. Mehta NJ, Khan IA, Gupta V, et al: Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock. Int J Cardiol 2004; 95:13-17
104. Parrillo JE, Burch C, Shelhamer JH, et al: A circulating myocardial depressant substance in humans with septic shock: Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest 1985; 76:1539-1553
105. 2+ handling and shortening in sepsis. Crit Care Med 2005; 33:598-604
106. Barth E, Radermacher P, Thiemermann C, et al: Role of inducible nitric oxide synthase in the reduced responsiveness of the myocardium to catecholamines in a hyperdynamic, murine model of septic shock. Crit Care Med 2006; 34:307-313
107. Lancel S, Joulin O, Favory R, et al: Ventricular myocyte caspases are directly responsible for endotoxin-induced cardiac dysfunction. Circulation 2005; 111:2596-2604
108. Singer M, Glynne P: Treating critical illness: The importance of first doing no harm. PLoS Med 2005; 2:e167